Neumora Therapeutics, Inc. (NMRA) Tops Q4 EPS by 25c

Neumora Therapeutics, Inc. (NASDAQ: NMRA) reported Q4 EPS of ($0.37), $0.25 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Neumora Therapeutics, Inc. (NMRA) click here.

You May Also Be Interested In

• US Eyes 7.5% China Overcapacity Tariffs Before Xi-Trump Talks - Bloomberg
• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
• Japan Eyes Tax Breaks For Non-core Business Sales In Governance Reform Push, Sources Say - Reuters